The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans
- 1 May 1992
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 102 (5) , 1742-1751
- https://doi.org/10.1016/0016-5085(92)91738-p
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Inhibition of Cholecystokinin-Stimulated Pancreaticobiliary Output in Man by the Cholecystokinin Receptor Antagonist MK-329Scandinavian Journal of Gastroenterology, 1991
- Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.Journal of Clinical Investigation, 1990
- Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.Journal of Clinical Investigation, 1989
- CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.Gut, 1989
- Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.Gut, 1989
- Concentrations of Secretin and CCK in Plasma and Pancreatico-biliary Secretion in Response to Intraduodenal Acid and FatPancreas, 1986
- Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin.Journal of Clinical Investigation, 1986
- Regulation of gastric emptying in humans by cholecystokinin.Journal of Clinical Investigation, 1986
- Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels.Journal of Clinical Investigation, 1985
- Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.Journal of Clinical Investigation, 1985